Drugs

Gilead and Merck’s once-weekly HIV pill passes two major trials

HQ Team June 10, 2026: Pharmaceutical giants Gilead Sciences and Merck announced that a once-weekly, single-tablet HIV treatment made up of islatravir and.

Read More